Heinz-Josef Lenz
Co-Director, USC Center for Molecular Pathway and Drug Discovery · University of Southern California/Los Angeles General Medical Center
Credentials: · ·
History
PresentUSC Center for Molecular Pathway and Drug Discovery · University of Southern California/Los Angeles General Medical Center
- Present
USC Norris Cancer Center for Cancer Drug Development · University of Southern California/Los Angeles General Medical Center
- 1989–1992
Hematology and Medical Oncology
- 1986–1989
Internal Medicine
- 1985–1986
- 1981–1985
Research
The Lancet · 2013 · 2,391 citations
The Lancet Oncology · 2017 · 2,298 citations
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy · 2021 · 2,291 citations
48 papers
47 papers
- RG
47 papers
- AB
44 papers · 1 as a fellow
- AS
41 papers
39 papers · 1 as a fellow
- CB
37 papers
35 papers · 3 as a fellow
Grants
- 2014–2032
NCTN - Network Lead Academic Participating Site: USC
National Cancer Institute · UG1
Contact PI · $3.2M · University of Southern California
- 2021–2027
National Cancer Institute · U2C
Contact PI · $19.3M · University of Southern California
- 2014–2027
Phase 1 and 2 Molecular and Clinical Pharmacodynamic Trials ETCTN
National Cancer Institute · UM1
PI · $19.6M · Beckman Research Institute/City of Hope
- 1996–2026
University of Southern California Norris Comprehensive Cancer Center Support Grant (CCSG)
National Cancer Institute · P30
Project lead · $302.5K · University of Southern California
Clinical trials
- 2022–2028
Confronting Cancer as a Community
Principal investigator · Recruiting
University of Southern California
- 2020–2021
Principal investigator · Terminated · Phase 2
University of Southern California
- 2020–2023
Guadecitabine and Nivolumab in Treating Refractory Metastatic Colorectal Cancer
Principal investigator · Withdrawn · Phase 1, Phase 2
University of Southern California
- 2019–2027
Regorafenib and Pembrolizumab in Treating Participants With Advanced or Metastatic Colorectal Cancer
Principal investigator · Active not recruiting · Phase 1, Phase 2
University of Southern California